Source: Annual Congress 2004 - Aspects of diagnosis - biology and infections in tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. K. Alenova, G. B. Rakishev, S. S. Chaimerdenov, A. T. Ismailova (Almaty, Kazakhstan). Role of interleukin-2 for patients with tuberculosis. Eur Respir J 2004; 24: Suppl. 48, 3934

Member's Comments

No comment yet.

Related content which might interest you: Levels of IL-1β and TNFα production in patients with lung tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 315s Year: 2002 Effect of isoniazid on antigen-specific interferon-? secretion in latent tuberculosis Source: Eur Respir J 2015; 45: 473-482 Year: 2015 Role of interferon-gamma quantification for the diagnosis of pleural tuberculosis: a meta-analysis Source: Eur Respir J 2001; 18: Suppl. 33, 499s Year: 2001 Role of cytokines in the immunopathogenesis of the MDR pulmonary tuberculosis Source: Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis Year: 2008 Cytokines in patients with tuberculosis pleurisy Source: Eur Respir J 2005; 26: Suppl. 49, 655s Year: 2005 Clinical utility of the interferon-gamma for the diagnosis of active pulmonary tuberculosis Source: Annual Congress 2011 - Risk assessment for tuberculosis Year: 2011 Profiles of tuberculosis disease activation among contacts of patients with tuberculosis Source: Eur Respir J, 54 (4) 1900353; 10.1183/13993003.00353-2019 Year: 2019 Angiogenic activity of sera from tuberculosis and sarcoidosis patients in relation to IL-12 and TNFα serum level Source: Annual Congress 2003 - Genetics and immunobiology of tuberculosis Year: 2003 Cytokine profile in patients with widespread MDR tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 504s Year: 2006 Prognostic values of serum IP-10 and IL-17 in patients with pulmonary tuberculosis Source: Annual Congress 2011 - Novel strategies for the diagnosis of tuberculosis Year: 2011 Evaluation of 242 patients with tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 470s Year: 2001 Comparison of the serum soluble IL-2 receptor levels in the differential diagnosis of pulmonary tuberculosis and lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 475s Year: 2001 Relationship between serum VEGF and tuberculous patients and non-tuberculousis mycobacterium patients Source: Eur Respir J 2003; 22: Suppl. 45, 341s Year: 2003 Effect of isoniazid prophylaxis for latent TB on interferon-gamma response Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease Year: 2007 Role of patients Source: ERS Summit on priorities in respiratory medicine 2011 Year: 2011 Characteristics of new tuberculosis cases diagnosed during treatment with TNF-alpha antagonists Source: Annual Congress 2009 - Clinical immunology of tuberculosis Year: 2009 Diagnosing latent tuberculosis in immunocompromised patients measuring blood IP-10 production capacity: An analysis of chronic renal faulire patients Source: International Congress 2015 – Screening strategies in TB Year: 2015 Clinical evaluation of interferon-gamma release assay (IGRA) in patients with nontuberculous mycobacterial disease Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012 Comparison of PPD and quantiferon tests in determining latent tuberculosis in patients who are directed to TNF antagonists Source: Annual Congress 2008 - Interferon-gamma methods for the diagnosis of tuberculosis infection and disease Year: 2008 Assessment of specific immunoglobulins in patients with lung tuberculosis Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections Year: 2017